Alexander L Gerbes1. 1. Medizinische Klinik II, Klinikum der Universität München, München, Germany.
Abstract
BACKGROUND: Renal failure in cirrhosis may be due to various causes. While treatment for patients with ascites and hepatorenal syndrome is established, recent attention has been focused on acute kidney injury (AKI) in cirrhosis. KEY MESSAGES: The reduction of centrally effective blood volume is the key to the pathophysiology of renal failure and ascites formation in cirrhosis. Therefore, albumin infusion following large volume paracentesis is recommended by all guidelines. In selected patients, transjugular intrahepatic portosystemic shunt provides good control of ascites and improves survival. The role of non-selective beta-blockers in patients with cirrhosis and ascites is being controversially discussed. AKI in cirrhosis has been redefined and has prognostic importance. CONCLUSIONS: The role of kidney function in patients with liver cirrhosis is receiving increasing attention. In particular, the use of beta-blockers and novel definitions of AKI seem to be of clinical relevance.
BACKGROUND:Renal failure in cirrhosis may be due to various causes. While treatment for patients with ascites and hepatorenal syndrome is established, recent attention has been focused on acute kidney injury (AKI) in cirrhosis. KEY MESSAGES: The reduction of centrally effective blood volume is the key to the pathophysiology of renal failure and ascites formation in cirrhosis. Therefore, albumin infusion following large volume paracentesis is recommended by all guidelines. In selected patients, transjugular intrahepatic portosystemic shunt provides good control of ascites and improves survival. The role of non-selective beta-blockers in patients with cirrhosis and ascites is being controversially discussed. AKI in cirrhosis has been redefined and has prognostic importance. CONCLUSIONS: The role of kidney function in patients with liver cirrhosis is receiving increasing attention. In particular, the use of beta-blockers and novel definitions of AKI seem to be of clinical relevance.
Authors: Zaid Haddadin; Vivian Lee; Christopher Conlin; Lei Zhang; Kristi Carlston; Glen Morrell; Daniel Kim; John M Hoffman; Kathryn Morton Journal: J Nucl Med Technol Date: 2017-02-02
Authors: Hamza Waqar Bhatti; Umama Tahir; Noman Ahmed Chaudhary; Sania Bhatti; Muhammad Hafeez; Zuhair Ali Rizvi Journal: BMJ Open Gastroenterol Date: 2019-05-19
Authors: Mauro Bernardi; Paolo Angeli; Joan Claria; Richard Moreau; Pere Gines; Rajiv Jalan; Paolo Caraceni; Javier Fernandez; Alexander L Gerbes; Alastair J O'Brien; Jonel Trebicka; Thierry Thevenot; Vicente Arroyo Journal: Gut Date: 2020-02-26 Impact factor: 23.059
Authors: Liliana Ducatti; Luciana B P Haddad; Alberto Meyer; Lucas S Nacif; Rubens M Arantes; Rodrigo B Martino; Vinicius Rocha-Santos; Daniel R Waisberg; Rafael S Pinheiro; Luiz A C D Albuquerque; Wellington Andraus Journal: Arq Bras Cir Dig Date: 2022-01-05
Authors: Thomas Reiberger; Andreas Püspök; Maria Schoder; Franziska Baumann-Durchschein; Theresa Bucsics; Christian Datz; Werner Dolak; Arnulf Ferlitsch; Armin Finkenstedt; Ivo Graziadei; Stephanie Hametner; Franz Karnel; Elisabeth Krones; Andreas Maieron; Mattias Mandorfer; Markus Peck-Radosavljevic; Florian Rainer; Philipp Schwabl; Vanessa Stadlbauer; Rudolf Stauber; Herbert Tilg; Michael Trauner; Heinz Zoller; Rainer Schöfl; Peter Fickert Journal: Wien Klin Wochenschr Date: 2017-10-23 Impact factor: 1.704